About: http://webisa.webdatacommons.org/201013305

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	The Food and Drug Administration approved Swiss drugmaker Novartis' treatment Gilenya to reduce relapses in patients with multiple sclerosis, who experiences loss of balance, muscle spasms and other movement problems.
http://www.w3.org/ns/prov#wasQuotedFrom	koaa.com